Key market opportunities include expansion into AI-driven signal detection, emphasis on personalized medicine, and adoption ...

Consolidating adverse event databases is a smart move, but without public education, real-time transparency risks becoming ...

The FDA has launched a unified Adverse Event Monitoring System (AEMS) to consolidate safety reports across all regulated products and is piloting real-time clinical trial monitoring. The move replaces ...

Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have revolutionized the management of metabolic diseases, offering substantial benefits in glycemic control, weight reduction, cardiovascular ...

The U.S. Food and Drug Administration has launched a nationwide Adverse Event Monitoring System powered by ThinkTrends' agentic AI to unify and automate drug safety reporting. The platform ...

Indian authorities have released version 2.0 of their pharmacovigilance guidance, enacting changes such as extending the deadline for reporting non-serious adverse events and revising record-keeping ...

Dublin, April 14, 2026 (GLOBE NEWSWIRE)-- The "AI in Pharmacovigilance (May 18, 2026)" training has been added to ResearchAndMarkets.com's offering. This course covers the fundamentals of AI ...

The European Medicines Agency (EMA) has released a new set of recommendations for postmarket surveillance for veterinary medicinal products, which will go into effect on 1 October 2015.

DUBLIN--(BUSINESS WIRE)--The "Advanced Veterinary Pharmacovigilance Training Course" conference has been added to ResearchAndMarkets.com's offering. This seminar will be beneficial to those who have ...

The new adverse event reporting service from the VMD will replace the previous suspended service. The Veterinary Medicines Directorate (VMD) is ...